AIGH Capital Management’s IN8bio INAB Stock Holding History

AIGH Capital Management’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-149,895	Closed	-$313K	–	46
2025 Q2	$313K	Buy	149,895 +101,562	+210%	+$413K	0.14%	35
2025 Q1	$241K	Sell	48,333 -158,063	-77%	-$1.26M	0.1%	40
2024 Q4	$1.59M	Buy	206,396 +150,575	+270%	+$1.32M	0.5%	29
2024 Q3	$452K	Sell	55,821 -15,112	-21%	-$274K	0.13%	37
2024 Q2	$1.8M	Sell	70,933 -24,899	-26%	-$799K	0.56%	28
2024 Q1	$3.39M	Sell	95,832 -40,780	-30%	-$1.54M	1.02%	29
2023 Q4	$5.22M	Buy	+136,612	New	+$4.37M	2.06%	20

Other funds holding INAB

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIGH Capital Management's INAB Position: Q3 2025 in Review

AIGH Capital Management sold out of IN8bio (INAB) in Q3 2025, closing a stake of 149,895 shares — an estimated $313K sold.

AIGH Capital Management first reported a position in INAB in Q4 2023 and held it in 7 quarters. The position peaked at $5.22M in Q4 2023. 19 funds tracked by Wall St. Rank hold INAB as of Q3 2025.

AIGH Capital Management reported no remaining IN8bio position as of Q3 2025 after selling out during the quarter.
AIGH Capital Management sold 149,895 IN8bio shares in Q3 2025, an estimated $313K.
AIGH Capital Management first reported a position in IN8bio in Q4 2023 and held it in 7 quarters.
AIGH Capital Management's IN8bio position peaked at $5.22M in Q4 2023.
19 funds tracked by Wall St. Rank held IN8bio as of Q3 2025.

Based on AIGH Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.